Expression of metallothionein gene at different time in testicular interstitial cells and liver of rats treated with cadmium

被引:27
作者
Ren, XY [1 ]
Zhou, Y [1 ]
Zhang, JP [1 ]
Feng, WH [1 ]
Jiao, BH [1 ]
机构
[1] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China
关键词
D O I
10.3748/wjg.v9.i7.1554
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Rodent testes are generally more susceptible to cadmium (Cd)-induced toxicity than liver. To clarify the molecular mechanism of Cd-induced toxicity in testes, we compared metallothionein (MT) gene expression, MT protein accumulation, and Cd retention at different time in freshly isolated testicular interstitial cells and liver of rats treated with Cd. METHODS: Adult male Sprague-Dawley rats weighing 250280 g received a s.c injection of 4.0 mumol Cd/kg and were euthanized by CO2 asphyxiation 1 h, 3 h, 6 h, or 24 h later. Tissue was sampled and testicular interstitial cells were isolated. There were three replicates per treatment and 3 animals per replicate for RNA analyses, others, three replicates per treatment and one animal per replicate. MT1 and MT2 mRNA levels were determined by semi-quantitative RT-PCR analysis followed by densitometry scanning, and MT was estimated by the enzyme-linked immunosorbent assay (ELISA) method. Cadmium content was determined by atomic absorption spectrophotometry. The same parametersd were also analyzed in the liver, since this tissue unquestionably accumulate MT. RESULTS: The rat testis expressed MT1 and MT2, the major isoforms. We also found that untreated animals contained relatively high basal levels of both isoform mRNA, which were increased after Cd treatment in liver and peaked at 3 h, followed by a decline. In contrast, the mRNA levels in interstitial cells peaked at 6 h. Interestingly, the induction of MT1 mRNA was lower than MT2 mRNA in liver of rat treated with Cd, but it was opposite to interstitial cells. Cd exposure substantially increased hepatic MT (3.9-fold increase), but did not increase MT translation in interstitial cells. CONCLUSION: Cd-induced expression of MT isoforms is not only tissue dependent but also time-dependent. The inability to induce the metal-detoxicating MT-protein in response to Cd, may account for a higher susceptibility of testes to Cd toxicity and carcinogenesis compared to liver.
引用
收藏
页码:1554 / 1558
页数:5
相关论文
共 32 条
[1]   Cadmium-induced mRNA expression of HSP32 is augmented in metallothionein-I and -II knock-out mice [J].
Abe, T ;
Yamamoto, O ;
Gotoh, S ;
Yan, Y ;
Todaka, N ;
Higashi, K .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 382 (01) :81-88
[2]   Stage-dependent accumulation of cadmium and induction of metallothionein-like binding activity in the testis of the dogfish shark, Squalus acanthias [J].
Betka, M ;
Callard, GV .
BIOLOGY OF REPRODUCTION, 1999, 60 (01) :14-22
[3]   Induction of metallothionein synthesis with preservation of testicular function in rats following long term renal transplantation [J].
Cai, L ;
Deng, DX ;
Jiang, J ;
Chen, S ;
Zhong, R ;
Cherian, MG ;
Chakrabarti, S .
UROLOGICAL RESEARCH, 2000, 28 (02) :97-103
[4]   MINIMAL BASAL ACTIVITY AND LACK OF METAL-INDUCED ACTIVATION OF THE METALLOTHIONEIN GENE CORRELATES WITH LOBE-SPECIFIC SENSITIVITY TO THE CARCINOGENIC EFFECTS OF CADMIUM IN THE RAT PROSTATE [J].
COOGAN, TP ;
SHIRAISHI, N ;
WAALKES, MP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 132 (01) :164-173
[5]   Rodent Leydig cell tumorigenesis: A review of the physiology, pathology, mechanisms, and relevance to humans [J].
Cook, JC ;
Klinefelter, GR ;
Hardisty, JF ;
Sharpe, RM ;
Foster, PMD .
CRITICAL REVIEWS IN TOXICOLOGY, 1999, 29 (02) :169-261
[6]  
Cyr DG, 2001, J ANDROL, V22, P124
[7]  
Dufresne J, 1999, J ANDROL, V20, P769
[8]  
Eid H, 1998, ANTICANCER RES, V18, P3059
[9]  
Klaassen Curtis D., 1998, Journal of Toxicological Sciences, V23, P97
[10]   Effects of cadmium on metallothionein-I and metallothionein-II mRNA expression in rat ventral, lateral, and dorsal prostatic lobes: Quantification by competitive RT-PCR [J].
Lee, KF ;
Lau, KM ;
Ho, SM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 154 (01) :20-27